Xenon Pharmaceuticals Announces Initiation of XEN801 Phase 1 Clinical Trial - Nasdaq

Xenon Pharmaceuticals Announces Initiation of XEN801 Phase 1 Clinical Trial Nasdaq 24, 2015 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced the initiation of a Phase 1 clinical trial of its lead proprietary program, XEN801, as a potential treatment for acne. and more »

acne treatment – Google News

Related Post

What Acne Scar Surgery Options Do You Have

The bride-to-be who almost refused to walk down th...

Premium Quality Face Facial Skin Care Set Kit of 2...

Dove Men+Care Body and Face Wash, Deep Clean 13.5 ...

Xenon Pharmaceuticals Announces Initiation of XEN801 Phase 1 Clinical Trial - Nasdaq